yea it looks like at first glance this could be a little oversold on a knee jerk reaction to some of the (bad news of course)
- but possibly the company prs later today or tomorrow about there gameplans to work with the FDA to address the issues that lead to the rejection-and this rallys back some of the losses especially for the longs in this over a $1.50 hopefully they can see .75+ again soon (rough morning for them)
Market Data 
Markets 
AI
